GLUE · Monte Rosa Therapeutics, Inc. · Documents
$10.27
-0.23 (-2.19%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$1.00B
Shares
85.31M
Volume · Oct 5
1.75M
Avg daily vol (3M)
1.3M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-10-01 | — | |
| 8-K | 2026-09-08 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-06-11 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-29 | — | |
| 8-K | 2026-03-17 | — | |
| 10-K | 2026-03-17 | 2025-12-31 | |
| 8-K | 2026-02-10 | 2026-02-09 | |
| 8-K | 2026-01-09 | 2026-01-08 | |
| 8-K | 2026-01-07 | — | |
| 8-K | 2026-01-07 | — | |
| 8-K | 2025-12-16 | — | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-09-15 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-13 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-25 | — | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-03-20 | — | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-12-13 | 2024-12-11 | |
| 8-K | 2024-12-05 | — | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-10-28 | 2024-10-25 | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-06-27 | — | |
| 8-K | 2024-06-12 | — | |
| 8-K | 2024-05-30 | 2024-05-28 | |
| 8-K | 2024-05-16 | 2024-05-15 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-02 | 2024-04-29 | |
| DEF 14A | 2024-04-26 | — | |
| 10-K | 2024-03-14 | 2023-12-31 | |
| 8-K | 2024-03-14 | — | |
| 8-K | 2024-01-08 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-10-26 | — | |
| 8-K | 2023-10-17 | 2023-10-16 | |
| 8-K | 2023-08-10 | — |
Showing 1–50 of 78 filings